Danielle M. Sloane


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.


Danielle Sloane helps national life science and healthcare companies navigate the complex maze of federal and state healthcare laws and regulations. With an analytical eye, Danielle helps her clients mitigate legal risk, innovate and achieve regulatory compliance consistent with their business goals. Clients rely on Danielle’s analytic capabilities in combination with her understanding of the dynamics of healthcare to provide practical and workable solutions.

Working with clients ranging from physician practices, hospitals and ambulatory surgical centers to clinical laboratories, medical device companies and imaging facilities, Danielle’s practice involves:

  • Compliance, Regulatory and Operational Matters – Analysis and counseling on various federal and state regulatory requirements and the operational impact on healthcare providers and suppliers; complex analysis of Stark, Anti-kickback and other fraud and abuse regulations, self-disclosure or voluntary repayments, corporate practice of medicine, Medicare/Medicaid reimbursement, participation and billing compliance, innovative payment models and other regulatory matters.
  • Mergers, Acquisitions & Joint Ventures – Assisting with the buying and selling of physician practices, surgery centers, labs and other types of providers; including structuring transactions, joint ventures and strategic partnerships or investment opportunities to meet business goals and comply with applicable healthcare laws; conducting healthcare due diligence of target entities to identify and resolve regulatory risks, including assisting with analysis of overpayments, repayments and self-disclosures.
  • Reimbursement, Value-Based Care Models – With a deep understanding of reimbursement rules, Danielle helps clients determine how they can best innovate and evolve to improve patient care within the confines of current healthcare regulatory laws. She advises on the challenges of creating value-based care arrangements including evaluations of fraud and abuse issues, contractual agreements, risk-sharing arrangements and payor relationships.
  • Government Investigations – Conducts internal investigations and assists with the substantive healthcare analysis necessary in responding to governmental inquiries conducted by the Office of Inspector General, United States Department of Justice, Centers for Medicare/Medicaid and state regulatory agencies.


American Health Law Association (AHLA) Life Sciences Practice Group, Vice Chair of Education (2023-2025)

Bloomberg Law Health Care Practice Innovation Board (2017-2019)

Leadership Health Care — Alumnus

Nashville Young Leaders Council — Alumnus